Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Vargas-Zambrano JC"'
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S451-S451
Autor:
Machado-Alba JE; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma SA, Pereira, Colombia., Machado-Duque ME; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma SA, Pereira, Colombia.; Grupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia., Gaviria-Mendoza A; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma SA, Pereira, Colombia.; Grupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia., Vargas-Zambrano JC; Global Medical Vaccines, Sanofi, Lyon, France.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2395685. Date of Electronic Publication: 2024 Sep 04.
Autor:
Calvo AE; College of Public Health, University of South Florida, Panama Program at City of Knowledge, Tampa, FL, USA.; Gorgas Memorial Institute for Health Studies, Panama City, Panama., Tristán Urrutia AG; Rollins School of Public Health, Emory University, Atlanta, GA, USA., Vargas-Zambrano JC; Global Medical Vaccines, Sanofi, Lyon, France., López Castillo H; Department of Health Sciences, College of Health Professions and Sciences, Academic Health Sciences Center, University of Central Florida, Orlando, FL, USA.; Department of Population Health Sciences, College of Medicine, Academic Health Sciences Center, University of Central Florida, Orlando, FL, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2389577. Date of Electronic Publication: 2024 Aug 20.
Autor:
Sánchez-González G; Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Av Universidad 655, Santa María Ahuacatitlán, 62100 Cuernavaca, Morelos, Mexico., Luna-Casas G; Estimatio, Health Economics and Outcome Research Services, Heriberto Frías 116-403, Col. Del Valle, Del. Benito Juárez, 03100 Mexico City, Mexico., Mascareñas C; Sanofi, Vaccines Medical, 14 Espace Henry Vallée, 69007 Lyon, France., Macina D; Sanofi, Vaccines Medical, 14 Espace Henry Vallée, 69007 Lyon, France., Vargas-Zambrano JC; Sanofi, Vaccines Medical, 14 Espace Henry Vallée, 69007 Lyon, France. Electronic address: Juan.Vargas@sanofi.com.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126085. Date of Electronic Publication: 2024 Jul 08.
Autor:
Yang TU; Faculty of Medicine, University of Helsinki, Helsinki, Finland., Vargas-Zambrano JC; Global Medical, Sanofi, Lyon, France., Park HA; Department of Public Health, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.; Department of Emergency Medicine, Hallym University, Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea., Jung CW; National Institute of Organ, Tissue and Blood Management, Ministry of Health and Welfare, Seoul, Republic of Korea., Kim D; Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea., Jee Y; Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 15; Vol. 19 (3), pp. 2278940. Date of Electronic Publication: 2023 Nov 13.
Autor:
Sánchez-González G; Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Av Universidad 655, Santa María Ahuacatitlán, 62100 Cuernavaca, Morelos, Mexico., Luna-Casas G; Estimatio, Health Economics and Outcome Research Services, Heriberto Frías 116-403, Col. Del Valle, Del. Benito Juárez, 03100 Mexico City, Mexico., Mascareñas C; Sanofi, Vaccines Medical, 14 Espace Henry Vallée, 69007 Lyon, France., Macina D; Sanofi, Vaccines Medical, 14 Espace Henry Vallée, 69007 Lyon, France., Vargas-Zambrano JC; Sanofi, Vaccines Medical, 14 Espace Henry Vallée, 69007 Lyon, France. Electronic address: Juan.Vargas@sanofi.com.
Publikováno v:
Vaccine [Vaccine] 2023 Sep 22; Vol. 41 (41), pp. 6105-6111. Date of Electronic Publication: 2023 Sep 01.
High coverage and timeliness of vaccination of children under 6 years of age in Risaralda, Colombia.
Autor:
Machado-Alba JE; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma SA, Pereira, Colombia., Machado-Duque ME; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma SA, Pereira, Colombia.; Grupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia., Vargas-Zambrano JC; PPH Global Medical, Sanofi, Lyon, France.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug; Vol. 19 (2), pp. 2257424. Date of Electronic Publication: 2023 Sep 18.
Autor:
Gentile A; Epidemiology, Ricardo Gutierrez Children's Hospital, Gallo 1330, Buenos Aires City, Argentina., Castellano VE; Epidemiology, Ricardo Gutierrez Children's Hospital, Gallo 1330, Buenos Aires City, Argentina., Pacchiotti A; Epidemiology, Ricardo Gutierrez Children's Hospital, Gallo 1330, Buenos Aires City, Argentina., Del Pino M; Epidemiology, Ricardo Gutierrez Children's Hospital, Gallo 1330, Buenos Aires City, Argentina., Bollón LR; Epidemiology, Ricardo Gutierrez Children's Hospital, Gallo 1330, Buenos Aires City, Argentina.; Stamboulian Vaccines Services, French 3085, Buenos Aires City, Argentina., Lieste M; Stamboulian Vaccines Services, French 3085, Buenos Aires City, Argentina., Deluca M; Stamboulian Vaccines Services, French 3085, Buenos Aires City, Argentina., Vargas-Zambrano JC; Global Medical, Sanofi Vaccines, 14 Espace Henri Vallee, Lyon, France.
Publikováno v:
Vaccine: X [Vaccine X] 2023 Jun 28; Vol. 14, pp. 100339. Date of Electronic Publication: 2023 Jun 28 (Print Publication: 2023).
Autor:
Vargas-Zambrano JC; Global Medical Evidence Generation, Sanofi, Lyon, France. Electronic address: juan.vargas@sanofi.com., Clark LR; Global Medical, Sanofi, Swiftwater, PA, USA., Johnson DR; Global Medical, Sanofi, Swiftwater, PA, USA., Monfredo C; Biostatistical Sciences, Sanofi, Marcy l'Etoile, France., Pool V; US Medical, Sanofi, Swiftwater, PA, USA., Li L; Epidemiology and Benefit Risk, Sanofi, Bridgewater, NJ, USA., Bouvet PE; Soladis, Lyon, France., Blangero Y; Soladis, Lyon, France., Macina D; Global Medical Evidence Generation, Sanofi, Lyon, France.
Publikováno v:
Vaccine [Vaccine] 2023 May 02; Vol. 41 (18), pp. 2968-2975. Date of Electronic Publication: 2023 Apr 07.
Autor:
Marjenberg Z; Maverex Limited, Newcastle upon Tyne, United Kingdom. Electronic address: ZoeMarjenberg@maverex.com., Wright C; Maverex Limited, Newcastle upon Tyne, United Kingdom. Electronic address: CiaraWright@maverex.com., Pooley N; Maverex Limited, Newcastle upon Tyne, United Kingdom. Electronic address: NickPooley@maverex.com., Cheung KW; Department of Obstetrics and Gynaecology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China. Electronic address: kelvincheung82@hotmail.com., Shimakawa Y; Unité d'Épidémiologie des Maladies Émergentes, Institut Pasteur, Paris, France. Electronic address: yusuke.shimakawa@gmail.com., Vargas-Zambrano JC; Sanofi, 14 espace Henry Vallée, 69007 Lyon, France. Electronic address: Juan.Vargas@sanofi.com., Vidor E; Sanofi, 14 espace Henry Vallée, 69007 Lyon, France. Electronic address: Emmanuel.Vidor@sanofi.com.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 Nov; Vol. 124, pp. 65-75. Date of Electronic Publication: 2022 Sep 09.